Balyasny Asset Management
COLL icon

Balyasny Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Balyasny Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
2025
Q1 		$1.4M Buy
2024
Q1 		– Sell
2023
Q4 		$456K Buy
2023
Q1 		– Sell
2022
Q4 		$3.89M Buy
2020
Q1 		– Sell
2019
Q4 		$219K Buy
2018
Q4 		– Sell
2018
Q3 		$497K Buy
2018
Q2 		– Sell
2018
Q1 		$448K Buy